End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19,020 KRW | -3.01% | -9.43% | +7.15% |
Apr. 24 | BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting | MT |
Apr. 10 | Uno Minda Secures Land for Alloy Wheel Plant in Haryana, India | MT |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 139,774 |
Enterprise Value (EV) 1 | 118,658 |
P/E ratio | -51.1 x |
Yield | - |
Capitalization / Revenue | 21.6 x |
EV / Revenue | 18.3 x |
EV / EBITDA | -94 x |
EV / FCF | -669 x |
FCF Yield | -0.15% |
Price to Book | 5.26 x |
Nbr of stocks (in thousands) | 7,875 |
Reference price 2 | 17,750 |
Announcement Date | 3/20/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2023 |
---|---|
Net sales 1 | 6,470 |
EBITDA 1 | -1,263 |
EBIT 1 | -2,239 |
Operating Margin | -34.6% |
Earnings before Tax (EBT) 1 | -1,949 |
Net income 1 | -2,327 |
Net margin | -35.97% |
EPS 2 | -347.3 |
Free Cash Flow 1 | -177.3 |
FCF margin | -2.74% |
FCF Conversion (EBITDA) | - |
FCF Conversion (Net income) | - |
Dividend per Share | - |
Announcement Date | 3/20/24 |
Income Statement Evolution (Quarterly data)
Fiscal Period: |
---|
Balance Sheet Analysis
Fiscal Period: December | 2023 |
---|---|
Net Debt 1 | - |
Net Cash position 1 | 21,117 |
Leverage (Debt/EBITDA) | - |
Free Cash Flow 1 | -177 |
ROE (net income / shareholders' equity) | -13.6% |
ROA (Net income/ Total Assets) | -6.18% |
Assets 1 | 37,662 |
Book Value Per Share 2 | 3,372 |
Cash Flow per Share 2 | 1,382 |
Capex 1 | 381 |
Capex / Sales | 5.89% |
Announcement Date | 3/20/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.15% | 113M | |
+15.13% | 87.2B | |
+20.07% | 72.13B | |
+17.25% | 36.82B | |
+23.37% | 34.67B | |
+11.38% | 28.34B | |
+4.43% | 27.06B | |
+6.60% | 26.98B | |
+22.73% | 26.3B | |
+19.81% | 25.5B |
- Stock Market
- Equities
- A451220 Stock
- Financials IMT Co., Ltd.